(Q44328472)

2 December 2017

title

Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism (English)

1 reference

2 December 2017

1 reference

Jennifer L Tillerson

1

1 reference

2 December 2017

Gary W Miller

series ordinal

2

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Journal of Neuroscience Methods

2 December 2017

published in

1 reference

2 December 2017

volume

123

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

189-200

1 reference

The pasta matrix reaching task: a simple test for measuring skilled reaching distance, direction, and dexterity in rats

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Intracellular calcium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Effects of MPTP on locomotor activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Neural degeneration and the transport of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP-induced hypoactivity in mice: reversal by L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

The MPTP-treated mouse as a model of parkinsonism: how good is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Dopamine transporter mutants selectively enhance MPP+ transport

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP toxicity: implications for research in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

The biotransformation of MPTP and disposition of MPP+: the effects of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Immunochemical analysis of dopamine transporter protein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP, MPP+ and mitochondrial function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Compulsive, Abnormal Walking Caused by Anticholinergics in Akinetic, 6-Hydroxydopamine-Treated Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Amine accumulation, catecholamine depletion and motor impairment in Macaca fasicularis and the C-57 black mouse after MPTP administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2802%2900360-6

7 January 2021

10.1016/S0165-0270(02)00360-6

Identifiers

DOI

1 reference

2 December 2017

1 reference